Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Fast-tracking C010DS-Zn: PARP1-agonist targeting cancer and M2-like macrophages Jinhyuk Fred Chung, PhD, Chief Scientific Officer, Xylonix Pte. Ltd. Parthanatos (a programmed necrosis from PARP1 hyperactivation) is an untapped death mechanism in oncology, and it offers some ideal features for cance... 2 years ago | 40 mins
